$QTRX Cashflow Statement | Understand Stock

$QTRX

$3.12 +$0.23 (7.96%) Close

$QTRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statement of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense
Inventory step-up amortization
Credit losses on accounts receivable
Reduction in the carrying amounts of right-of-use assets
Unrealized losses (gains) on foreign currency transactions
Accretion of marketable securities
Operating lease right-of-use asset amortization
Stock-based compensation expense
Impairment
Goodwill impairment
Impairment of long-lived assets
Non-cash interest expense
Change in fair value of contingent liabilities
Recognition of off-market liability
Deferred taxes
Loss on disposal of fixed assets
Other operating activity
Changes in assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Other non-current assets
Accounts payable
Accrued compensation and benefits, accrued expenses, and other current liabilities
Contract acquisition costs
Deferred revenue
Operating lease liabilities
Other non-current liabilities
Net change in other operating assets and liabilities

Net cash used in operating activities
Cash flows from investing activities:
Purchases of marketable debt securities
Proceeds from sales and maturities of marketable securities
Purchases of property and equipment
Proceeds from RADx grant on assets purchased
Acquisitions, net of cash acquired
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from stock options exercised
Proceeds from common stock issued under stock plans
Payments for employee taxes withheld on stock-based compensation awards
Payments on notes payable
Net cash provided by (used in) financing activities

Net increase in cash and cash equivalents
Net decrease in cash, cash equivalents, and restricted cash
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period
Supplemental disclosure of cash flow information:
Cash paid for taxes

Purchases of property and equipment included in accounts payable and other accrued expenses
Cash paid for interest
Common stock issued in exchange for acquisition of Akoya
Purchases of property and equipment in accounts payable and accruals
Operating lease right-of-use assets obtained in exchange for lease liabilities
Non-cash consideration received under product sales agreement (Note 3, 6)

Comments